Cutler Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2132 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2033 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1869 |
|
|
2020
Q1 | – | Sell |
-2,725
| Closed | -$177K | – | 1801 |
|
|
2019
Q4 | $177K | Buy |
+2,725
| New | +$177K | 0.01% | 545 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1863 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1950 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1884 |
|
|
2018
Q1 | – | Sell |
-231
| Closed | -$19K | – | 2172 |
|
|
2017
Q4 | $19K | Hold |
231
| – | – | ﹤0.01% | 1407 |
|
|
2017
Q3 | $19K | Buy |
+231
| New | +$19K | ﹤0.01% | 1657 |
|
|
2017
Q2 | – | Sell |
-7,573
| Closed | -$499K | – | 3067 |
|
|
2017
Q1 | $499K | Sell |
7,573
-17,586
| -70% | -$1.16M | 0.02% | 471 |
|
|
2016
Q4 | $1.59M | Buy |
25,159
+19,137
| +318% | +$1.21M | 0.06% | 187 |
|
|
2016
Q3 | $383K | Buy |
6,022
+5,642
| +1,485% | +$359K | 0.02% | 480 |
|
|
2016
Q2 | $28K | Sell |
380
-792
| -68% | -$58.4K | ﹤0.01% | 1664 |
|
|
2016
Q1 | $78K | Buy |
1,172
+590
| +101% | +$39.3K | 0.01% | 1060 |
|
|
2015
Q4 | $39K | Buy |
+582
| New | +$39K | ﹤0.01% | 1538 |
|